High-resolution mass spectrometry will dramatically change our drug-discovery bioanalysis procedures

Bioanalysis

Volumn 3, Issue 11, 2011, Pages 1169-1171

  Korfmacher, Walter ^a  

^a DMPK and MS Imaging   (United States)

Author keywords

drug discovery; high resolution; HRMS; lead optimization; paradigm shift; qualitative quantitative; SRM

Indexed keywords

ACCURACY; DRUG DETERMINATION; DRUG INDUSTRY; DRUG METABOLISM; DRUG RESEARCH; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PROCESS OPTIMIZATION; QUANTITATIVE ANALYSIS; REVIEW; TANDEM MASS SPECTROMETRY;

DRUG DISCOVERY; MASS SPECTROMETRY; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; PHARMACOLOGICAL PROCESSES; TIME FACTORS;

EID: 79958695977     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.11.98     Document Type: Review

References (14)

1. Korfmacher W. Bioanalytical assays in a drug discovery environment. In: Using Mass Spectrometry for Drug Metabolism Studies. Korfmacher W (Ed.). CRC Press, Boca Raton, FL, USA 1-34 (2005).
2. Korfmacher WA. Principles and applications of LC-MS in new drug discovery. Drug Discov. Today 10(20), 1357-1367 (2005). (Pubitemid 41501790)
3. Korfmacher WA, Cox KA, Bryant MS, Veals J, Ng K, Lin CC. HPLC-API/MS/MS: a powerful tool for integrating drug metabolism into the drug discovery process. Drug Discov. Today 2, 532-537 (1997). (Pubitemid 27512943)
4. Yu K, Little D, Plumb R, Smith B. High-throughput quantification for a drug mixture in rat plasma - a comparison of ultra performance liquid chromatography/tandem mass spectrometry with high-performance liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 20(4), 544-552 (2006). (Pubitemid 43236839)
5. Wainhaus S. Fast chromatography with UPLC and other techniques. In: Using Mass Spectrometry for Drug Metabolism Studies (Second Edition). Korfmacher W (Ed.). CRC Press, Boca Raton, FL, USA 255-275 (2010).
6. Wainhaus S, Nardo C, Anstatt R, Wang S, Dunn-Meynell K, Korfmacher W. Ultra fast liquid chromatography-MS/MS for pharmacokinetic and metabolic profiling within drug discovery. Am. Drug Discov. 2(1), 6-12 (2007).
7. Korfmacher WA. Advances in the integration of drug metabolism into the lead optimization paradigm. Mini Rev. Med. Chem. 9(6), 703-716 (2009).
8. Zhang NR, Yu S, Tiller P, Yeh S, Mahan E, Emary WB. Quantitation of small molecules using high-resolution accurate mass spectrometers - a different approach for analysis of biological samples. Rapid Commun. Mass Spectrom. 23(7), 1085-1094 (2009).
9. Bateman KP, Kellmann M, Muenster H, Papp R, Taylor L. Quantitative-qualitative data acquisition using a benchtop Orbitrap mass spectrometer. J. Am. Soc. Mass Spectrom. 20(8), 1441-1450 (2009).
10. Kaufmann A, Butcher P, Maden K, Walker S, Widmer M. Quantitative and confirmative performance of liquid chromatography coupled to high-resolution mass spectrometry compared with tandem mass spectrometry. Rapid Commun. Mass Spectrom. 25(7), 979-992 (2011).
11. Kerns E, Di L. Drug-like Properties: Concepts, Structure Design and Methods from ADME to Toxicity Optimization. Elsevier/Academic Press, NY, USA (2008).
12. Zhang H, Ma L, He K, Zhu M. An algorithm for thorough background subtraction from high-resolution LC/MS data: application to the detection of troglitazone metabolites in rat plasma, bile, and urine. J. Mass Spectrom. 43(9), 1191-1200 (2008).
13. Zhu M, Ma L, Zhang D et al. Detection and characterization of metabolites in biological matrices using mass defect filtering of liquid chromatography/high resolution mass spectrometry data. Drug Metab. Dispos. 34(10), 1722-1733 (2006). (Pubitemid 44427475)
14. Biocius Life Sciences. www.biocius.com/pr/rf360-high-resolution-time-of- flight-mass-spec-ADME-screening.html